GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » Construction In Progress

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Construction In Progress : ¥2,341 Mil (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zhejiang Huahai Pharmaceutical Co Construction In Progress?

Zhejiang Huahai Pharmaceutical Co's quarterly construction in progress declined from Sep. 2023 (¥3,358 Mil) to Dec. 2023 (¥2,317 Mil) but then increased from Dec. 2023 (¥2,317 Mil) to Mar. 2024 (¥2,341 Mil).

Zhejiang Huahai Pharmaceutical Co's annual construction in progress increased from Dec. 2021 (¥2,502 Mil) to Dec. 2022 (¥2,803 Mil) but then declined from Dec. 2022 (¥2,803 Mil) to Dec. 2023 (¥2,317 Mil).

Zhejiang Huahai Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for Zhejiang Huahai Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Huahai Pharmaceutical Co Construction In Progress Chart

Zhejiang Huahai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 929.85 1,157.50 2,502.41 2,802.56 2,316.90

Zhejiang Huahai Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,950.51 3,211.15 3,357.95 2,316.90 2,341.18

Zhejiang Huahai Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Huahai Pharmaceutical Co Ltd (SHSE:600521) » Definitions » Construction In Progress
Comparable Companies
SHSE:600518 SHSE:600329 SHSE:600380 SZSE:002262 SHSE:600062 SHSE:603707 SZSE:300142 SHSE:600535 SHSE:600129 SZSE:002773 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
Economic Development Zone, Xunqiao Town, Linhai, Taizhou, Zhejiang, CHN, 317024
Website
http://www.huahaipharm.com
Zhejiang Huahai Pharmaceutical Co Ltd provides formulations, active pharmaceutical ingredients, and intermediates in China and internationally. The company also offers pril products, including captopril, enalapril, and lisinopril.
Executives
Chen Bao Hua Director
Shang Fei senior management
Du Jun Director
Su Yan Director
Chen Dun Yuan senior management
Li Hong Director
Guo Si Jia senior management
Li Min senior management
Xu Bo senior management
Wang Jie senior management
Chen Qi Mao senior management
Zhang Hong senior management
Zhang Mei senior management
Zhu Yong Hua Directors, senior managers
Wang Yi Hua senior management

Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Headlines

No Headlines